About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Ponent: Leona Knox, Head of Research at Solving Kids’ Cancer UK.
Leona Knox is Head of Research at Solving Kids’ Cancer UK, a non-profit organisation fostering international collaboration to accelerate pioneering clinical research in neuroblastoma. Leona is a passionate advocate dedicated to multi-stakeholder working for the benefit of children with cancer, and actively participates in several academic committees and working groups to help inform research agendas and influence policy. She is founding Chair of the SIOPEN Advocate Committee, a member of the ITCC Advocate Committee, and previously served as a member of the AACR Pediatric Working Group Steering Committee and ACCELERATE Steering Committee. Leona’s son Oscar died of neuroblastoma in 2014 following extensive therapy in the UK and US.
This talk reflects on the transition from being a parent of a child with cancer to structured involvement in European research networks. From personal experience, it highlights the importance of meaningful involvement and practical ways to build partnerships that enhance research.
Host:*Dr. Lucas Moreno Martín-Retortillo, Head of the Pediatric Oncology and Hematology Service at Vall d'Hebron University Hospital and Head of the Childhood Cancer and Hematological Diseases Research Group. Vall d'Hebron Research Institute (VHIR).
*Sara Mas Assens, Head of Impact and Responsible Research and Innovation (RRI) - Internal Strategy Department. Vall d'Hebron Research Institute (VHIR).
Online: https://gencat.zoom.us/j/81197810307
